formulation based on polimetafosfati for treatment of arthropathy microcrystalline.

摘要

Soluble pharmaceutical composition for the treatment of articular pathologies comprising an effective amount of a least one linear or cyclic polymetaphosphate or a soluble and pharmaceutically acceptable salt thereof, and appropriate diluents.